{"id":"https://openalex.org/W1995114136","doi":"https://doi.org/10.1046/j.1471-4159.1995.65062633.x","title":"1\u2010Benzyl\u20101,2,3,4\u2010Tetrahydroisoquinoline as a Parkinsonism\u2010Inducing Agent: A Novel Endogenous Amine in Mouse Brain and Parkinsonian CSF","display_name":"1\u2010Benzyl\u20101,2,3,4\u2010Tetrahydroisoquinoline as a Parkinsonism\u2010Inducing Agent: A Novel Endogenous Amine in Mouse Brain and Parkinsonian CSF","alternate_titles":[],"publication_year":1995,"publication_date":"1995-12-01","ids":{"openalex":"https://openalex.org/W1995114136","doi":"https://doi.org/10.1046/j.1471-4159.1995.65062633.x","mag":"1995114136","pmid":"https://pubmed.ncbi.nlm.nih.gov/7595560"},"language":"en","primary_location":{"id":"doi:10.1046/j.1471-4159.1995.65062633.x","doi":"https://doi.org/10.1046/j.1471-4159.1995.65062633.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.1995.65062633.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995114136"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081312271","display_name":"Yaichiro Kotake","orcid":"https://orcid.org/0000-0003-2645-3078","observed_orcids":["https://orcid.org/0000-0003-2645-3078"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yaichiro Kotake","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, University of Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, University of Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038527025","display_name":"Yoshikazu Tasaki","orcid":"https://orcid.org/0000-0002-0340-038X","observed_orcids":["https://orcid.org/0000-0002-0340-038X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshikazu Tasaki","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103081882","display_name":"Yukiko Makino","orcid":"https://orcid.org/0000-0001-5137-7981","observed_orcids":["https://orcid.org/0000-0001-5137-7981"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yukiko Makino","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111515298","display_name":"Shigeru Ohta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shigeru Ohta","raw_affiliation_strings":["Faculty of Medicine, University of Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030608289","display_name":"Masaaki Hirobe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Masaaki Hirobe","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030608289"],"corresponding_institution_ids":[],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":4.7525,"has_fulltext":false,"cited_by_count":161,"citation_normalized_percentile":{"value":0.95163006,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"65","issue":"6","first_page":"2633","last_page":"2638"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13971","display_name":"Isoquinoline Alkaloid Synthesis","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endogenous-amines","display_name":"endogenous amines","score":0.8240000009536743},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9670000076293945},{"id":"https://openalex.org/keywords/brain-neurochemistry","display_name":"brain neurochemistry","score":0.4819999933242798},{"id":"https://openalex.org/keywords/1-methyl-1-2-3-4-tetrahydroisoquinoline","display_name":"1-methyl-1,2,3,4-tetrahydroisoquinoline","score":0.9440000057220459},{"id":"https://openalex.org/keywords/parkinsonism","display_name":"parkinsonism","score":0.5849999785423279},{"id":"https://openalex.org/keywords/behavioral-abnormalities","display_name":"behavioral abnormalities","score":0.578000009059906},{"id":"https://openalex.org/keywords/pole-test","display_name":"pole test","score":0.7250000238418579},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.8162565231323242},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.7420387268066406},{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.6091475486755371},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.5811786651611328},{"id":"https://openalex.org/C2776406546","wikidata":"https://www.wikidata.org/wiki/Q411677","display_name":"Tetrahydroisoquinoline","level":2,"score":0.547465980052948},{"id":"https://openalex.org/C131779359","wikidata":"https://www.wikidata.org/wiki/Q471875","display_name":"Amine gas treating","level":2,"score":0.534619152545929},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43121784925460815},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42770087718963623},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3762987554073334},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3662601113319397},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35845130681991577},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3313658833503723},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001679","descriptor_name":"Biogenic Amines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008401","descriptor_name":"Gas Chromatography-Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1471-4159.1995.65062633.x","doi":"https://doi.org/10.1046/j.1471-4159.1995.65062633.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.1995.65062633.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:7595560","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7595560","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W119693908","https://openalex.org/W2414779619","https://openalex.org/W2131820064","https://openalex.org/W2077875270","https://openalex.org/W2009090011","https://openalex.org/W2949281068","https://openalex.org/W2003901994","https://openalex.org/W1984368342","https://openalex.org/W2016095227"],"abstract_inverted_index":{"1-Benzyl-1,2,3,4-tetrahydroisoquinoline":[0],"(1BnTIQ)":[1],"was":[2,26,92],"detected":[3],"as":[4],"a":[5,81],"novel":[6],"endogenous":[7],"amine":[8],"in":[9,29,101],"mouse":[10],"brain":[11],"and":[12],"parkinsonian":[13,33],"CSF":[14,30],"by":[15],"using":[16],"the":[17,44,96,124],"gas":[18],"chromatography-selected":[19],"ion-monitoring":[20],"method.":[21],"The":[22,78],"level":[23],"of":[24,31,38,56,67,99,105],"1BnTIQ":[25,100,106,119],"very":[27],"high":[28],"some":[32],"patients":[34],"compared":[35],"with":[36,40,112],"that":[37,118],"controls":[39],"other":[41],"neurological":[42],"diseases,":[43],"mean":[45,72],"value":[46],"being":[47],"three":[48],"times":[49],"higher":[50],"(parkinsonians:":[51],"1.17":[52],"+/-":[53,64,73],"0.35":[54],"ng/ml":[55,66],"CSF,":[57,68],"n":[58,69],"=":[59,70],"18;":[60],"vs.":[61],"controls:":[62],"0.40":[63],"0.10":[65],"11;":[71],"SEM,":[74],"not":[75],"significantly":[76],"different).":[77],"pole":[79],"test,":[80],"toxicological":[82],"examination":[83],"to":[84,89,94,123],"evaluate":[85],"behavior":[86,108],"abnormalities":[87],"related":[88,122],"Parkinson's":[90,126],"disease,":[91],"used":[93],"examine":[95],"pharmacological":[97],"effect":[98],"mice.":[102],"Repeated":[103],"administration":[104],"induced":[107],"abnormalities,":[109],"which":[110],"pretreatment":[111],"1-methyl-1,2,3,4-tetrahydroisoquinoline":[113],"could":[114],"prevent.":[115],"We":[116],"suggest":[117],"may":[120],"be":[121],"idiopathic":[125],"disease.":[127]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995114136","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
